Terms: = Head and neck cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Treatment
199 results:
1. Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment.
Raguz J; Pinto C; Pölzlbauer T; Habbeddine M; Rosskopf S; Strauß J; Just V; Schmidt S; Bidet Huang K; Stemeseder F; Schippers T; Stewart E; Jez J; Berraondo P; Orlinger KK; Lauterbach H
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631709
[TBL] [Abstract] [Full Text] [Related]
2. LymphoDose: a lymphocyte dose estimation framework-application to brain radiotherapy.
de Kermenguy F; Benzazon N; Maury P; Vauclin R; M'hamdi M; Cifliku V; Limkin E; Diallo I; Morel D; Milewski C; Clémenson C; Mondini M; Deutsch E; Robert C
Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38593817
[No Abstract] [Full Text] [Related]
3. A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.
Wu H; Liu C; Yuan Q; Qiao Y; Ding Y; Duan L; Li W; Zhang M; Zhang X; Jiang Y; Lu J; Dong Z; Wang T; Liu K; Zhao J
Oncoimmunology; 2023; 12(1):2282250. PubMed ID: 38126034
[TBL] [Abstract] [Full Text] [Related]
4. fgfr1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.
Chu YH; Mullaney K; DiNapoli SE; Cohen MA; Xu B; Ghossein R; Katabi N; Dogan S
Histopathology; 2024 Mar; 84(4):589-600. PubMed ID: 38010295
[TBL] [Abstract] [Full Text] [Related]
5. Elevation of H3K27me3 level contributes to the radioresistance of nasopharyngeal carcinoma by inhibiting OAS1 expression.
Zhou Y; Xiao Y; Liu H; Chen Q; Zhu L; Zeng L; Liu X; Pan Y; Zhang J; Fu J; Shao C
Am J Physiol Cell Physiol; 2024 Jan; 326(1):C60-C73. PubMed ID: 38009194
[TBL] [Abstract] [Full Text] [Related]
6. B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC.
Chen B; Zheng K; Fang S; Huang K; Chu C; Zhuang J; Lin J; Li S; Yao H; Liu A; Liu G; Lin J; Lin X
J Nanobiotechnology; 2023 Oct; 21(1):378. PubMed ID: 37848956
[TBL] [Abstract] [Full Text] [Related]
7. Multi-kinase compensation rescues EGFR knockout in a cell line model of head and neck squamous cell carcinoma.
Ludwig ML; Michmerhuizen NL; Wang J; Birkeland AC; Majchrowski BK; Nimmagadda S; Zhai J; Bhangale A; Kulkarni A; Jiang H; Swiecicki PL; Brenner JC
Arch Oral Biol; 2023 Dec; 156():105822. PubMed ID: 37844343
[TBL] [Abstract] [Full Text] [Related]
8. Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma.
Nguyen Vu TH; Kikuchi O; Ohashi S; Saito T; Ida T; Nakai Y; Cao Y; Yamamoto Y; Kondo Y; Mitani Y; Kataoka S; Kondo T; Katada C; Yamada A; Matsubara J; Muto M
Cancer Sci; 2023 Dec; 114(12):4664-4676. PubMed ID: 37724648
[TBL] [Abstract] [Full Text] [Related]
9. Combination
Gunda V; Ghosh C; Hu J; Zhang L; Zhang YQ; Shen M; Kebebew E
Thyroid; 2023 Oct; 33(10):1201-1214. PubMed ID: 37675898
[No Abstract] [Full Text] [Related]
10. Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma.
Mann JE; Smith JD; Kulkarni A; Foltin SK; Scheftz EB; Murray IR; Gensterblum-Miller E; Brummel CV; Bhangale A; Hoesli RC; Brenner JC
Oral Oncol; 2023 Nov; 146():106562. PubMed ID: 37666053
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic analysis and treatment utilization of different treatment strategies in elderly esophageal cancer patients with distant metastases: a SEER database analysis.
Han LQ; Cui TT; Xiao NJ; Li W
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15413-15423. PubMed ID: 37644234
[TBL] [Abstract] [Full Text] [Related]
12. Somatic rearrangements causing oncogenic ectodomain deletions of fgfr1 in squamous cell lung cancer.
Malchers F; Nogova L; van Attekum MH; Maas L; Brägelmann J; Bartenhagen C; Girard L; Bosco G; Dahmen I; Michels S; Weeden CE; Scheel AH; Meder L; Golfmann K; Schuldt P; Siemanowski J; Rehker J; Merkelbach-Bruse S; Menon R; Gautschi O; Heuckmann JM; Brambilla E; Asselin-Labat ML; Persigehl T; Minna JD; Walczak H; Ullrich RT; Fischer M; Reinhardt HC; Wolf J; Büttner R; Peifer M; George J; Thomas RK
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37606995
[TBL] [Abstract] [Full Text] [Related]
13. A novel microenvironment regulated system CAR-T (MRS.CAR-T) for immunotherapeutic treatment of esophageal squamous carcinoma.
Wang L; Wang X; Wu Y; Wang J; Zhou W; Wang J; Guo H; Zhang N; Zhang L; Hu X; Zhao Y; Miao J; Zhang Z; Chard Dunmall LS; Zhang D; Lemoine NR; Cheng Z; Wang Y
Cancer Lett; 2023 Aug; 568():216303. PubMed ID: 37422126
[TBL] [Abstract] [Full Text] [Related]
14. Futibatinib, an Irreversible fgfr1-4 Inhibitor for the treatment of FGFR-Aberrant Tumors.
Javle M; King G; Spencer K; Borad MJ
Oncologist; 2023 Nov; 28(11):928-943. PubMed ID: 37390492
[TBL] [Abstract] [Full Text] [Related]
15. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription.
Yang Z; Liu F; Li Z; Liu N; Yao X; Zhou Y; Zhang L; Jiang P; Liu H; Kong L; Lang C; Xu X; Jia J; Nakajima T; Gu W; Zheng L; Zhang Z
Clin Epigenetics; 2023 May; 15(1):92. PubMed ID: 37237385
[TBL] [Abstract] [Full Text] [Related]
16. Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy.
Sadeghirad H; Liu N; Monkman J; Ma N; Cheikh BB; Jhaveri N; Tan CW; Warkiani ME; Adams MN; Nguyen Q; Ladwa R; Braubach O; O'Byrne K; Davis M; Hughes BGM; Kulasinghe A
Front Immunol; 2023; 14():1135489. PubMed ID: 37153589
[TBL] [Abstract] [Full Text] [Related]
17. EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression.
Chen H; Duan X; Deng X; Huang Y; Zhou X; Zhang S; Zhang X; Liu P; Yang C; Liu G; Ren Q; Xiong Y; Zhu B; Zhang J; Xiang T
Cancer Immunol Res; 2023 Jun; 11(6):830-846. PubMed ID: 36996321
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of endogenous hydrogen sulfide production suppresses the growth of nasopharyngeal carcinoma cells.
Wang DY; Zhang J; Li HX; Zhang YX; Jing MR; Cai CB; Wang D; Qi HW; Wang YZ; Chen HJ; Li T; Zhai YK; Ji XY; Wu DD
Mol Carcinog; 2023 May; 62(5):652-664. PubMed ID: 36752346
[TBL] [Abstract] [Full Text] [Related]
19. A drug screening to identify novel combinatorial strategies for boosting cancer immunotherapy efficacy.
Zhang Z; Wang G; Zhong K; Chen Y; Yang N; Lu Q; Yuan B; Wang Z; Li H; Guo L; Zhang R; Wu Z; Zheng M; Zhao S; Tang X; Shao B; Tong A
J Transl Med; 2023 Jan; 21(1):23. PubMed ID: 36635683
[TBL] [Abstract] [Full Text] [Related]
20. Significant association between fgfr1 mutation frequency and age in central giant cell granuloma.
Niada S; Varazzani A; Giannasi C; Fusco N; Armiraglio E; Di Bernardo A; Cherchi A; Baj A; Corradi D; Tafuni A; Parafioriti A; Ferrero S; Bianchi AE; Giannì AB; Poli T; Latif F; Brini AT
Pathology; 2023 Apr; 55(3):329-334. PubMed ID: 36428107
[TBL] [Abstract] [Full Text] [Related]
[Next]
